Gene: QPCTL
Official Full Name: glutaminyl-peptide cyclotransferase likeprovided by HGNC
Gene Summary: Enables glutaminyl-peptide cyclotransferase activity and zinc ion binding activity. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14769 | QPCTL Knockout cell line (HeLa) | Human | QPCTL | 1:3~1:6 | Negative | Online Inquiry |
KO14770 | QPCTL Knockout cell line (HCT 116) | Human | QPCTL | 1:2~1:4 | Negative | Online Inquiry |
KO14771 | QPCTL Knockout cell line (HEK293) | Human | QPCTL | 1:3~1:6 | Negative | Online Inquiry |
KO14772 | QPCTL Knockout cell line (A549) | Human | QPCTL | 1:3~1:4 | Negative | Online Inquiry |
QPCTL Gene Knockout Cell Lines are sophisticated biological tools designed for the precise study of the QPCTL gene, which encodes a vital enzyme involved in protein modification and cellular signaling pathways. These cell lines have been genetically modified through CRISPR-Cas9 technology to disable the QPCTL gene, thereby allowing researchers to investigate the functional consequences of its loss on cellular behavior and metabolic processes.
The primary mechanism by which QPCTL Gene Knockout Cell Lines operate lies in their ability to simulate the absence of functional QPCTL protein, facilitating studies on its role in various cellular responses. By leveraging these knockout models, scientists can delineate the biochemical pathways influenced by the QPCTL enzyme, assess changes in cellular metabolism, and explore potential repercussions on disease mechanisms, particularly in cancer biology and neurodegeneration.
The scientific importance of these cell lines is underscored by their wide applicability in both research and clinical settings. They serve as powerful models for elucidating the pathological roles of QPCTL in disorders such as cancer metastasis and neuroinflammatory conditions, providing crucial insights that can drive the discovery of new therapeutic targets or strategies.
Unlike traditional gene knockdown methods, QPCTL Gene Knockout Cell Lines offer a stable and permanent alteration of gene expression, allowing for long-term studies with reproducibility. This durability signifies a significant advantage over transient transfection methods and ensures that experimental results are consistent across various research applications.
For researchers and clinicians, the value of QPCTL Gene Knockout Cell Lines lies in their ability to accelerate the understanding of complex biological interactions and disease mechanisms. Their robustness opens doors for innovative research approaches, ultimately contributing to advancements in therapeutic development.
Our company specializes in the creation and supply of high-quality genetic models, ensuring that our products meet rigorous scientific standards. With expert knowledge in genetic engineering and a commitment to advancing biomedical research, we equip researchers with the tools necessary to unlock the mysteries of gene function and interaction.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.